{"denoms":[{"counts":[{"groupId":"BG000","value":"238"},{"groupId":"BG001","value":"241"},{"groupId":"BG002","value":"111"},{"groupId":"BG003","value":"590"}],"units":"Participants"}],"groups":[{"description":"Bendamustine + Rituximab in participants with CLL without del(17p); bendamustine 90 milligrams (mg)/m\\^2/day administered intravenously (IV) on the first 2 days of each cycle for 6 cycles; rituximab 375 mg/m\\^2 for Cycle 1 and 500 mg/m\\^2 for Cycles 2 to 6 (each cycle is 28 days)","id":"BG000","title":"Cohort 1: Bendamustine + Rituximab Without Del(17p)"},{"description":"Zanubrutinib in participants with CLL without del(17p); 160 mg administered twice a day orally until unacceptable toxicity or disease progression","id":"BG001","title":"Cohort 1: Zanubrutinib Without Del(17p)"},{"description":"Zanubrutinib in participants with CLL with del(17p); 160 mg administered twice a day orally until unacceptable toxicity or disease progression","id":"BG002","title":"Cohort 2: Zanubrutinib With Del(17p)"},{"description":"Total of all reporting groups","id":"BG003","title":"Total"}],"measures":[{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}],"title":"<=18 years"},{"measurements":[{"groupId":"BG000","value":"46"},{"groupId":"BG001","value":"45"},{"groupId":"BG002","value":"16"},{"groupId":"BG003","value":"107"}],"title":"Between 18 and 65 years"},{"measurements":[{"groupId":"BG000","value":"192"},{"groupId":"BG001","value":"196"},{"groupId":"BG002","value":"95"},{"groupId":"BG003","value":"483"}],"title":">=65 years"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Age, Categorical","unitOfMeasure":"Participants"},{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"94"},{"groupId":"BG001","value":"87"},{"groupId":"BG002","value":"32"},{"groupId":"BG003","value":"213"}],"title":"Female"},{"measurements":[{"groupId":"BG000","value":"144"},{"groupId":"BG001","value":"154"},{"groupId":"BG002","value":"79"},{"groupId":"BG003","value":"377"}],"title":"Male"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Sex: Female, Male","unitOfMeasure":"Participants"},{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"5"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"10"}],"title":"Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"211"},{"groupId":"BG001","value":"218"},{"groupId":"BG002","value":"99"},{"groupId":"BG003","value":"528"}],"title":"Not Hispanic or Latino"},{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"11"},{"groupId":"BG003","value":"52"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Ethnicity (NIH/OMB)","unitOfMeasure":"Participants"},{"calculatePct":false,"classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}],"title":"American Indian or Alaska Native"},{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"14"}],"title":"Asian"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"1"}],"title":"Native Hawaiian or Other Pacific Islander"},{"measurements":[{"groupId":"BG000","value":"1"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"5"}],"title":"Black or African American"},{"measurements":[{"groupId":"BG000","value":"206"},{"groupId":"BG001","value":"221"},{"groupId":"BG002","value":"105"},{"groupId":"BG003","value":"532"}],"title":"White"},{"measurements":[{"groupId":"BG000","value":"0"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"0"},{"groupId":"BG003","value":"0"}],"title":"More than one race"},{"measurements":[{"groupId":"BG000","value":"22"},{"groupId":"BG001","value":"11"},{"groupId":"BG002","value":"5"},{"groupId":"BG003","value":"38"}],"title":"Unknown or Not Reported"}]}],"paramType":"COUNT_OF_PARTICIPANTS","title":"Race (NIH/OMB)","unitOfMeasure":"Participants"}],"populationDescription":"Intent-to-treat analysis set included all enrolled participants who were assigned to a treatment group (as of cut-off date of 07MAY2021)"}